Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling. 2010

Michele M Castro, and Elen Rizzi, and Cibele M Prado, and Marcos A Rossi, and Jose E Tanus-Santos, and Raquel Fernanda Gerlach
Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, Brazil.

Structural vascular changes in two-kidney, one-clip (2K-1C) hypertension may result from increased matrix metalloproteinase (MMP)-2 activity. MMP-2 activation is regulated by other MMPs, including transmembrane-MMPs, and by tissue inhibitors of MMPs (TIMPs). We have investigated the localization of MMP-2, -9, -14, and TIMPs 1-4 in hypertensive aortas and measured their levels by zymography/Western blotting and immunohistochemistry. Gelatinolytic activity was assayed in tissues by in situ zymography. Sham-operated and 2K-1C hypertensive rats were treated with doxycycline (or vehicle) for 8 weeks, and the systolic blood pressure was monitored weekly. Doxycycline attenuated 2K-1C hypertension (165 + or - 11.7 mmHg versus 213 + or - 7.9 mm Hg in hypertensive controls, P<0.01), and completely prevented increase in the thicknesses of the media and the intima in 2K-1C animals (P<0.01). Increased amounts of MMP-2, -9, and -14 were found in hypertensive aortas, as well as enhanced gelatinolytic activity. A gradient in the localization of MMP-2, -9, and -14 was found, with increased amounts detected in the intima, at sites with higher gelatinolytic activity. Doxycycline attenuated hypertension induced increases in all the 3 investigated MMPs in both the media and the intima (all P<0.05), but it did not change the amounts of TIMPs 1-4 (P>0.05). Therefore, an imbalance between increased amounts of MMPs at the tissue level without a corresponding increase in the quantities of TIMPs, particularly in the intima and inner media layers, appears to account for the increased proteolytic activity found in 2K-1C hypertension-induced maladaptive vascular remodeling.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004318 Doxycycline A synthetic tetracycline derivative with similar antimicrobial activity. 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-,Alpha-6-Deoxyoxytetracycline,Atridox,BMY-28689,BU-3839T,Doryx,Doxycycline Calcium,Doxycycline Calcium Salt (1:2),Doxycycline Hemiethanolate,Doxycycline Hyclate,Doxycycline Monohydrate,Doxycycline Monohydrochloride, 6-epimer,Doxycycline Monohydrochloride, Dihydrate,Doxycycline Phosphate (1:1),Doxycycline-Chinoin,Hydramycin,Oracea,Periostat,Vibra-Tabs,Vibramycin,Vibramycin Novum,Vibravenos,Alpha 6 Deoxyoxytetracycline,BMY 28689,BMY28689,BU 3839T,BU3839T,Doxycycline Chinoin,Doxycycline Monohydrochloride, 6 epimer,Vibra Tabs
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005109 Extracellular Matrix A meshwork-like substance found within the extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which cells or cell lysates in culture dishes adhere. Matrix, Extracellular,Extracellular Matrices,Matrices, Extracellular
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001011 Aorta The main trunk of the systemic arteries. Aortas

Related Publications

Michele M Castro, and Elen Rizzi, and Cibele M Prado, and Marcos A Rossi, and Jose E Tanus-Santos, and Raquel Fernanda Gerlach
July 2007, Hypertension (Dallas, Tex. : 1979),
Michele M Castro, and Elen Rizzi, and Cibele M Prado, and Marcos A Rossi, and Jose E Tanus-Santos, and Raquel Fernanda Gerlach
June 2004, Zhonghua yi xue za zhi,
Michele M Castro, and Elen Rizzi, and Cibele M Prado, and Marcos A Rossi, and Jose E Tanus-Santos, and Raquel Fernanda Gerlach
January 2018, Advances in pharmacology (San Diego, Calif.),
Michele M Castro, and Elen Rizzi, and Cibele M Prado, and Marcos A Rossi, and Jose E Tanus-Santos, and Raquel Fernanda Gerlach
July 2001, Thrombosis and haemostasis,
Michele M Castro, and Elen Rizzi, and Cibele M Prado, and Marcos A Rossi, and Jose E Tanus-Santos, and Raquel Fernanda Gerlach
January 2003, Journal of atherosclerosis and thrombosis,
Michele M Castro, and Elen Rizzi, and Cibele M Prado, and Marcos A Rossi, and Jose E Tanus-Santos, and Raquel Fernanda Gerlach
October 2005, Current vascular pharmacology,
Michele M Castro, and Elen Rizzi, and Cibele M Prado, and Marcos A Rossi, and Jose E Tanus-Santos, and Raquel Fernanda Gerlach
November 2021, Biochemical pharmacology,
Michele M Castro, and Elen Rizzi, and Cibele M Prado, and Marcos A Rossi, and Jose E Tanus-Santos, and Raquel Fernanda Gerlach
February 2020, Phlebology,
Michele M Castro, and Elen Rizzi, and Cibele M Prado, and Marcos A Rossi, and Jose E Tanus-Santos, and Raquel Fernanda Gerlach
July 2008, American heart journal,
Michele M Castro, and Elen Rizzi, and Cibele M Prado, and Marcos A Rossi, and Jose E Tanus-Santos, and Raquel Fernanda Gerlach
January 2008, Biochemical pharmacology,
Copied contents to your clipboard!